IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery
| Status: | Recruiting |
|---|---|
| Conditions: | Chronic Pain, Obesity Weight Loss, Post-Surgical Pain |
| Therapuetic Areas: | Endocrinology, Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 10/19/2013 |
| Start Date: | June 2010 |
The Effect of Systemic Intraoperative Lidocaine on Postoperative Pain and Quality of Recovery on Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery
Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve
quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use
of intraoperative systemic lidocaine decrease postoperative opioid consumption and improve
quality of recovery after laparoscopic gastric bypass surgery.
This study has the potential to confirm an opioid sparing strategy for morbid obese patients
undergoing laparoscopic gastric bypass surgery. The high incidence of obstructive sleep
apnea and the increased risk of postoperative hypoxemia make the development of opioid
sparing techniques in this patient population warranted.
Inclusion Criteria:
- ASA I, II,III;
- BMI > 35 kg/m2,
- Age between 18-70,
- Fluent in English,
- Patients undergoing laparoscopic gastric bypass,
- EKG within 3 months.
Exclusion Criteria:
- History of allergy to local anesthetics,
- History of chronic opioid use,
- Pregnant patients,
- History of EKG abnormalities.
Dropout: Conversion to open, patient or surgeon request.
We found this trial at
1
site
Northwestern Memorial Hospital Northwestern Memorial is an academic medical center hospital where the patient comes...
Click here to add this to my saved trials
